大腸鏡檢查設備市場- 按產品類型（大腸鏡、視覺化系統）、應用（結直腸癌、林奇症候群、潰瘍性結腸炎、克隆氏症）、最終用途（醫院、門診手術中心） - 全球預測，2024 - 2032 年

由於全球大腸直腸癌發生率不斷上升，2024 年至 2032 年大腸鏡檢查設備市場規模預計將以 5% 的複合CAGR成長。

根據世界衛生組織的數據，大腸直腸癌是世界上第三大常見疾病，約佔所有癌症診斷的 10%，也是癌症相關死亡的第二大原因。隨著全球人口迅速老化和生活方式的改變，大腸癌的盛行率將繼續上升，從而推動對大腸鏡檢查程序和設備的需求。此外，大腸鏡檢查設備的先進技術，例如改進的成像和導航系統，正在提高診斷準確性，進一步加速產業成長。例如，2024年2月，Magentiq推出了人工智慧輔助大腸鏡檢查工具，將腺瘤的識別和切除率提高了7%，降低了罹患結直腸癌的幾​​率。

大腸鏡檢查設備產業按產品類型、應用、最終用途和地區進行細分。

就產品類型而言，預計2024-2032年可視化系統領域的市值複合CAGR為4.9%。高清 (HD) 和超高清 (UHD) 攝影機等創新以及窄帶成像 (NBI) 和虛擬色素內視鏡技術正在增強結直腸疾病的檢測和診斷。這些先進的可視化系統可提供更清晰、詳細的結腸影像，從而提高病變識別的準確性並降低漏診率。此外，人工智慧輔助影像分析的整合進一步增強了診斷能力，顯著提高了產品的接受度。

根據應用情況，預計到 2032 年，林奇症候群細分市場的大腸鏡檢查設備市場複合CAGR將達到4.6%。林奇症候群(LS) 是最常見的遺傳性大腸直腸癌(CRC)疾病，其人群頻率為 2% 至3%。%。這種疾病的滲透使得對定期大腸鏡檢查以進行早期發現和監測的需求激增。林奇症候群的盛行率不斷上升，加上人們的認知和基因檢測的不斷提高，推動了對用於有效篩檢和監測的大腸鏡檢查設備的需求。色素內視鏡和高清成像等先進技術也提高了對林奇症候群患者至關重要的病變檢出率，從而促進了該細分市場的成長。

從地區來看，亞太地區大腸鏡檢查設備產業預計 2024 年至 2032 年將呈現 6.2% 的成長率。人們對大腸直腸癌的認知不斷提高，加上醫療保健支出不斷增加，刺激了對大腸鏡檢查的需求。政府不斷努力改善醫療基礎設施，從而促進預防性醫療保健。此外，該地區人口老化和飲食習慣的變化導致大腸直腸疾病的增加，需要更多的篩檢程序。此外，醫療技術的進步和微創手術的廣泛採用也推動了區域市場的擴張。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 對微創手術的需求不斷成長
    • 技術進步
    • 大腸直腸癌的發生率和盛行率不斷增加
  • 產業陷阱與挑戰
    • 與大腸鏡檢查程序相關的風險
• 成長潛力分析
• 波特的分析
• PESTEL分析
• 報銷場景
• 監管環境
• 技術景觀
• 未來市場趨勢
• 缺口分析

第 4 章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按產品類型，2018 年 - 2032 年

• 主要趨勢
• 大腸鏡
• 可視化系統
• 其他產品類型

第 6 章：市場估計與預測：按應用分類，2018 年 - 2032 年

• 主要趨勢
• 大腸直腸癌
• 林奇綜合症
• 潰瘍性結腸炎
• 克隆氏症
• 其他應用

第 7 章：市場估計與預測：按最終用途，2018 - 2032 年

• 主要趨勢
• 醫院
• 門診手術中心
• 其他最終用戶

第 8 章：市場估計與預測：按地區分類，2018 年 - 2032 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第 9 章：公司簡介

• Endomed Systems
• Fujifilm Holdings Corporation
• GI-View
• Medtronic plc
• Olympus Corporation
• Ottomed Endoscopy
• PENTAX Medical
• Smart Medical Systems Ltd.
• Steris PLC
• Stryker Corporation

Colonoscopy Devices Market size is poised to expand at 5% CAGR from 2024 to 2032 driven by the increasing incidence of colorectal cancer worldwide.

As per WHO, colorectal cancer is the third most frequent disease in the world, accounting for around 10% of all cancer diagnoses, and the second biggest cause of cancer-related fatalities. With the rapidly aging global population and lifestyle changes, the prevalence of colorectal cancer will continue to rise, fueling the demand for colonoscopy procedures and devices. Additionally, advanced technologies in colonoscopy devices, such as improved imaging and navigation systems are enhancing diagnostic accuracy, further accelerating the industry growth. For instance, in February 2024, Magentiq launched its AI-aided colonoscopy tool to improve the identification and removal of adenomas by 7%, lowering the chance of getting colorectal cancer.

The colonoscopy devices industry is segmented in product type, application, end-use, and region.

In terms of product type, the market value from the visualization systems segment is anticipated to witness 4.9% CAGR from 2024-2032. Innovations, such as high-definition (HD) and ultra-high-definition (UHD) cameras, along with narrow-band imaging (NBI) and virtual chromoendoscopy technologies are enhancing the detection and diagnosis of colorectal diseases. These advanced visualization systems offer clearer, detailed images of the colon for improving accuracy in lesion identification and reducing miss rates. Additionally, the integration of AI-assisted image analysis is further augmenting the diagnostic capabilities, fueling the product acceptance significantly.

Based on application, the colonoscopy devices market from the Lynch syndrome segment is projected to record 4.6% CAGR through 2032. Lynch syndrome (LS) is the most prevalent hereditary colorectal cancer (CRC) condition, with a population frequency ranging from 2% to 3%. This disease penetration is surging the need for regular colonoscopies for early detection and surveillance. The rising prevalence of Lynch Syndrome, coupled with increasing awareness and genetic testing is driving the demand for colonoscopy devices tailored for effective screening and monitoring. Advanced technologies, such as chromoendoscopy and high-definition imaging are also enhancing the rate of lesion detection crucial for Lynch Syndrome patients, boosting the segment growth.

Regionally, the Asia Pacific colonoscopy devices industry is projected to exhibit 6.2% growth rate from 2024-2032. The increasing awareness about colorectal cancer coupled with rising healthcare expenditures are fueling the demand for colonoscopy procedures. The growing government efforts to improve healthcare infrastructure is promoting preventive healthcare. Additionally, the aging population and changing dietary habits in the region are contributing to the rise in colorectal diseases, necessitating more screening procedures. Moreover, advancements in medical technologies and the higher adoption of minimally invasive procedures are also driving the regional market expansion.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & calculations
• 1.3 Data collection
• 1.4 Forecast parameters
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising demand for minimally invasive procedures
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Increasing incidence and prevalence of colorectal cancer
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Risk associated with colonoscopy procedures
• 3.3 Growth potential analysis
• 3.4 Porter's analysis
  • 3.4.1 Supplier power
  • 3.4.2 Buyer power
  • 3.4.3 Threat of new entrants
  • 3.4.4 Threat of substitutes
  • 3.4.5 Industry rivalry
• 3.5 PESTEL analysis
• 3.6 Reimbursement scenario
• 3.7 Regulatory landscape
• 3.8 Technological landscape
• 3.9 Future market trends
• 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Colonoscope
• 5.3 Visualization systems
• 5.4 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Colorectal cancer
• 6.3 Lynch syndrome
• 6.4 Ulcerative colitis
• 6.5 Crohn's disease
• 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Ambulatory surgical centers
• 7.4 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Endomed Systems
• 9.2 Fujifilm Holdings Corporation
• 9.3 GI-View
• 9.4 Medtronic plc
• 9.5 Olympus Corporation
• 9.6 Ottomed Endoscopy
• 9.7 PENTAX Medical
• 9.8 Smart Medical Systems Ltd.
• 9.9 Steris PLC
• 9.10 Stryker Corporation